Morgan Stanley’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.57M Buy
137,849
+58,681
+74% +$1.09M ﹤0.01% 4551
2025
Q1
$1.44M Sell
79,168
-36,881
-32% -$669K ﹤0.01% 4807
2024
Q4
$2.53M Buy
116,049
+48,764
+72% +$1.06M ﹤0.01% 4543
2024
Q3
$1.84M Buy
67,285
+40,324
+150% +$1.1M ﹤0.01% 4709
2024
Q2
$698K Buy
26,961
+5,877
+28% +$152K ﹤0.01% 5146
2024
Q1
$633K Buy
21,084
+20,974
+19,067% +$629K ﹤0.01% 5203
2023
Q4
$1.14K Sell
110
-45
-29% -$468 ﹤0.01% 7189
2023
Q3
$2.12K Sell
155
-899
-85% -$12.3K ﹤0.01% 7120
2023
Q2
$12.8K Sell
1,054
-31,261
-97% -$379K ﹤0.01% 6721
2023
Q1
$411K Buy
32,315
+27,334
+549% +$348K ﹤0.01% 5363
2022
Q4
$31.5K Buy
4,981
+4,018
+417% +$25.4K ﹤0.01% 6491
2022
Q3
$22K Sell
963
-900
-48% -$20.6K ﹤0.01% 6746
2022
Q2
$35K Buy
1,863
+830
+80% +$15.6K ﹤0.01% 6769
2022
Q1
$49K Sell
1,033
-698
-40% -$33.1K ﹤0.01% 6714
2021
Q4
$123K Buy
1,731
+547
+46% +$38.9K ﹤0.01% 6315
2021
Q3
$138K Sell
1,184
-2,526
-68% -$294K ﹤0.01% 6191
2021
Q2
$581K Buy
3,710
+3,655
+6,645% +$572K ﹤0.01% 5432
2021
Q1
$10K Sell
55
-22,870
-100% -$4.16M ﹤0.01% 6934
2020
Q4
$2.88M Buy
22,925
+5,628
+33% +$706K ﹤0.01% 3830
2020
Q3
$1.88M Buy
17,297
+3,891
+29% +$423K ﹤0.01% 3701
2020
Q2
$1.61M Buy
13,406
+13,301
+12,668% +$1.6M ﹤0.01% 3792
2020
Q1
$10K Sell
105
-1,519
-94% -$145K ﹤0.01% 6009
2019
Q4
$394K Buy
1,624
+1,274
+364% +$309K ﹤0.01% 5067
2019
Q3
$57K Buy
350
+334
+2,088% +$54.4K ﹤0.01% 5666
2019
Q2
$4K Sell
16
-131
-89% -$32.8K ﹤0.01% 6349
2019
Q1
$39K Sell
147
-228
-61% -$60.5K ﹤0.01% 5768
2018
Q4
$34K Sell
375
-639
-63% -$57.9K ﹤0.01% 5865
2018
Q3
$195K Buy
1,014
+983
+3,171% +$189K ﹤0.01% 5463
2018
Q2
$7K Buy
+31
New +$7K ﹤0.01% 6368